Tag archive for ‘Israeli biopharmaceutical company’

RedHill Biopharma Acquires Technology from University of Minnesota

– The University of Minnesota is buying rights for the development of a diagnostic Crohn’s disease test. Israeli RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) , has entered into a license agreement More...

Jewish Business News On Thursday, June 26th, 2014

Positive Preliminary Pre-Clinical Data for RedHill Biopharma for the Treatment of Type 1 Diabetes

RedHill Biopharma Ltd.(NASDAQ: RDHL; TASE: RDHL) , today announced preliminary positive data from a pre-clinical study with RHB-104 for the treatment of type 1 diabetes, a chronic autoimmune disease with More...

Press Release On Tuesday, January 14th, 2014

RedHill Biopharma Announces Definitive Agreement for $11.7 Million Private Placement

– Press release TEL-AVIV, Israel, January 14, 2014, RedHill Biopharma Ltd. (NASDAQ: RDHL; TASE: RDHL) (the “Company” or “RedHill”), an emerging Israeli biopharmaceutical company More...

RedHill Biopharma Announces Definitive Agreement for $6 Million Private Placement from OrbiMed

– RedHill Biopharma Ltd. (Nasdaq: RDHL; TASE: RDHL),  today announced that it has entered into a definitive agreement with leading healthcare investor OrbiMed Israel Partners Limited Partnership,  More...

Wordpress site Developed by Fixing WordPress Problems